SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Martine Dhilly, Stéphane Guillouet, Delphine patin, Fabien Fillesoye, Ahmed Abbas, Fabienne Gourand, Olivier Tirel, Françoise Galateau, Eric T. MacKenzie, Charles Dumontet, Michel Leporrier, Louisa Barré, 2-[18F]Fludarabine, a Novel Positron Emission Tomography (PET) Tracer for Imaging Lymphoma: a Micro-PET Study in Murine Models, Molecular Imaging and Biology, 2014, 16, 1, 118

    CrossRef

  2. 2
    Lale Kostakoglu, Bruce D. Cheson, Current role of FDG PET/CT in lymphoma, European Journal of Nuclear Medicine and Molecular Imaging, 2014, 41, 5, 1004

    CrossRef

  3. 3
    Giorgio Treglia, Emanuele Zucca, Ramin Sadeghi, Franco Cavalli, Luca Giovanella, Luca Ceriani, Detection rate of fluorine-18-fluorodeoxyglucose positron emission tomography in patients with marginal zone lymphoma of MALT type: a meta-analysis, Hematological Oncology, 2014, 32, 3
  4. 4
    Y. Shigematsu, T. Hirai, K. Kawanaka, S. Shiraishi, M. Yoshida, M. Kitajima, H. Uetani, M. Azuma, Y. Iryo, Y. Yamashita, Distinguishing Imaging Features between Spinal Hyperplastic Hematopoietic Bone Marrow and Bone Metastasis, American Journal of Neuroradiology, 2014, 35, 10, 2013

    CrossRef

  5. 5
    Christelle Tychyj-Pinel, Fabien Ricard, Michael Fulham, Marion Fournier, Michel Meignan, Thierry Lamy, Pierre Vera, Gilles Salles, Judith Trotman, PET/CT assessment in follicular lymphoma using standardized criteria: central review in the PRIMA study, European Journal of Nuclear Medicine and Molecular Imaging, 2014, 41, 3, 408

    CrossRef

  6. 6
    Andrea Gallamini, Anna Borra, Role of PET in Lymphoma, Current Treatment Options in Oncology, 2014, 15, 2, 248

    CrossRef

  7. 7
    Ruimin Wang, Haiyan Zhu, Yingmao Chen, Can Li, Fei Li, Zhihui Shen, Jiahe Tian, Li Yu, Baixuan Xu, Standardized uptake value based evaluation of lymphoma by FDG and FLT PET/CT, Hematological Oncology, 2014, 32, 3
  8. 8
    Inas El-Najjar, Silvia Montoto, Amy McDowell, Janet Matthews, John Gribben, Teresa A. Szyszko, The value of semiquantitative analysis in identifying diffuse bone marrow involvement in follicular lymphoma, Nuclear Medicine Communications, 2014, 35, 3, 311

    CrossRef

  9. 9
    Sally Fiona Barrington, Nabegh George Mikhaeel, When should FDG-PET be used in the modern management of lymphoma?, British Journal of Haematology, 2014, 164, 3
  10. 10
    Kheng-Wei Yeoh, N. George Mikhaeel, Are We Ready for Positron Emission Tomography/Computed Tomography-based Target Volume Definition in Lymphoma Radiation Therapy?, International Journal of Radiation Oncology*Biology*Physics, 2013, 85, 1, 14

    CrossRef

  11. 11
    Onofrio A. Catalano, Bruce R. Rosen, Dushyant V. Sahani, Peter F. Hahn, Alexander R. Guimaraes, Mark G. Vangel, Emanuele Nicolai, Andrea Soricelli, Marco Salvatore, Clinical Impact of PET/MR Imaging in Patients with Cancer Undergoing Same-Day PET/CT: Initial Experience in 134 Patients—A Hypothesis-generating Exploratory Study, Radiology, 2013, 131306

    CrossRef

  12. 12
    Onofrio A. Catalano, Bruce R. Rosen, Dushyant V. Sahani, Peter F. Hahn, Alexander R. Guimaraes, Mark G. Vangel, Emanuele Nicolai, Andrea Soricelli, Marco Salvatore, Clinical Impact of PET/MR Imaging in Patients with Cancer Undergoing Same-Day PET/CT: Initial Experience in 134 Patients—A Hypothesis-generating Exploratory Study, Radiology, 2013, 269, 3, 857

    CrossRef

  13. 13
    Regine Kluge, Lars Kurch, Françoise Montravers, Christine Mauz-Körholz, FDG PET/CT in children and adolescents with lymphoma, Pediatric Radiology, 2013, 43, 4, 406

    CrossRef

  14. 14
    Masashi Nakadate, Katsuya Yoshida, Akihiro Ishii, Masayuki Koizumi, Naobumi Tochigi, Yoshio Suzuki, Yoshiharu Ryu, Tassei Nakagawa, Isao Umehara, Hitoshi Shibuya, Is 18F-FDG PET/CT Useful for Distinguishing Between Primary Thyroid Lymphoma and Chronic Thyroiditis?, Clinical Nuclear Medicine, 2013, 38, 9, 709

    CrossRef

  15. 15
    Peter Martin, Bijal Shah, Limited-stage mantle cell lymphoma: not so different from advanced-stage, Leukemia & Lymphoma, 2013, 54, 2, 217

    CrossRef

  16. 16
    Alireza Rezaee, Xianfeng Frank Zhao, Vasken Dilsizian, Wengen Chen, Pediatric Presentation of Splenic Marginal Zone Lymphoma on FDG PET/CT Scan, Clinical Nuclear Medicine, 2013, 1

    CrossRef

  17. 17
    Laurent Gilardin, Christiane Copie-Bergman, Lionel Galicier, Véronique Meignin, Josette Brière, Julie F. Timsit, Olivier Bouchaud, Philippe Gaulard, Eric Oksenhendler, Laurence Gérard, Peripheral T-cell lymphoma in HIV-infected patients: a study of 17 cases in the combination antiretroviral therapy era, British Journal of Haematology, 2013, 161, 6
  18. 18
    Martin Allen-Auerbach, Sven de Vos, Johannes Czernin, PET/Computed Tomography and Lymphoma, Radiologic Clinics of North America, 2013, 51, 5, 833

    CrossRef

  19. 19
    Pier Luigi Zinzani, Monia Marchetti, Atto Billio, Giovanni Barosi, Angelo Michele Carella, Mario Lazzarino, Maurizio Martelli, Alessandro Rambaldi, Luigi Rigacci, Corrado Tarella, Umberto Vitolo, Sante Tura, SIE, SIES, GITMO revised guidelines for the management of follicular lymphoma, American Journal of Hematology, 2013, 88, 3
  20. 20
    S. Luminari, I. Biasoli, L. Arcaini, A. Versari, C. Rusconi, F. Merli, M. Spina, A. J. M. Ferreri, P. L. Zinzani, A. Gallamini, S. Mastronardi, C. Boccomini, G. Gaidano, A. M. D'Arco, F. Di Raimondo, A. M. Carella, A. Santoro, P. Musto, M. Federico, The use of FDG-PET in the initial staging of 142 patients with follicular lymphoma: a retrospective study from the FOLL05 randomized trial of the Fondazione Italiana Linfomi, Annals of Oncology, 2013, 24, 8, 2108

    CrossRef

  21. 21
    Hugo J. A. Adams, Thomas C. Kwee, Malou A. Vermoolen, Bart de Keizer, John M. H. de Klerk, Judit A. Adam, Rob Fijnheer, Marie José Kersten, Jaap Stoker, Rutger A. J. Nievelstein, Whole-body MRI for the detection of bone marrow involvement in lymphoma: prospective study in 116 patients and comparison with FDG-PET, European Radiology, 2013, 23, 8, 2271

    CrossRef

  22. 22
    M. J. Shelly, S. McDermott, O. J. O'Connor, M. A. Blake, 18-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in the Management of Aggressive Non-Hodgkin's B-Cell Lymphoma, ISRN Hematology, 2012, 2012, 1

    CrossRef

  23. 23
    K. Bouharati-Moussa, D. Papathanassiou, A. Benaissa, C. Portefaix, C. Bruna-Muraille, A. Delmer, B. Kolb, J.-C. Liehn, C. Marcus, Comparaison de l’IRM de diffusion et de la TEP/TDM au FDG dans le bilan des lymphomes, Médecine Nucléaire, 2012, 36, 9, 504

    CrossRef

  24. 24
    Motoko Yamaguchi, Current and future management of NK/T-cell lymphoma based on clinical trials, International Journal of Hematology, 2012, 96, 5, 562

    CrossRef

  25. 25
    Takayoshi Shinya, Soichiro Fujii, Shoji Asakura, Toshitaka Taniguchi, Kotaro Yoshio, Aierken Alafate, Shuhei Sato, Tadashi Yoshino, Susumu Kanazawa, Dual-time-point F-18 FDG PET/CT for evaluation in patients with malignant lymphoma, Annals of Nuclear Medicine, 2012, 26, 8, 616

    CrossRef

  26. 26
    Egesta Lopci, Lucia Zanoni, Arturo Chiti, Cristina Fonti, Ivan Santi, Pier Luigi Zinzani, Stefano Fanti, FDG PET/CT predictive role in follicular lymphoma, European Journal of Nuclear Medicine and Molecular Imaging, 2012, 39, 5, 864

    CrossRef

  27. 27
    James O. Armitage, My Treatment Approach to Patients With Diffuse Large B-Cell Lymphoma, Mayo Clinic Proceedings, 2012, 87, 2, 161

    CrossRef

  28. 28
    Stephen M. Ansell, James O. Armitage, Positron Emission Tomographic Scans in Lymphoma: Convention and Controversy, Mayo Clinic Proceedings, 2012, 87, 6, 571

    CrossRef

  29. 29
    Arutselvan Natarajan, Gayatri Gowrishankar, Carsten H. Nielsen, Sen Wang, Andrei Iagaru, Michael L. Goris, Sanjiv Sam Gambhir, Positron Emission Tomography of 64Cu-DOTA-Rituximab in a Transgenic Mouse Model Expressing Human CD20 for Clinical Translation to Image NHL, Molecular Imaging and Biology, 2012, 14, 5, 608

    CrossRef

  30. 30
    Anthony R. Mato, Jakub Svoboda, Tatyana Feldman, Tania Zielonka, Harry Agress, David Panush, Mitchell Miller, Patrick Toth, Paul M. Lizotte, Sunita Nasta, Stuart Goldberg, Emeline Chong, Steven Schuster, Andrew L. Pecora, Andre Goy, Post-treatment (not interim) positron emission tomography-computed tomography scan status is highly predictive of outcome in mantle cell lymphoma patients treated with R-HyperCVAD, Cancer, 2012, 118, 14
  31. 31
    Luca Arcaini, Sara Rattotti, Manuel Gotti, Stefano Luminari, Prognostic Assessment in Patients with Indolent B-Cell Lymphomas, The Scientific World Journal, 2012, 2012, 1

    CrossRef

  32. 32
    Xavier Setoain, Armando López-Guillermo, Estadificación de los linfomas no hodgkinianos con PET-TC, Medicina Clínica, 2011, 137, 9, 402

    CrossRef

  33. You have free access to this content33
    Claire E. Dearden, Rod Johnson, Ruth Pettengell, Stephen Devereux, Kate Cwynarski, Sean Whittaker, Andrew McMillan, Guidelines for the management of mature T-cell and NK-cell neoplasms (excluding cutaneous T-cell lymphoma), British Journal of Haematology, 2011, 153, 4
  34. 34
    M.S. Hofman, R.J. Hicks, Imaging in follicular NHL, Best Practice & Research Clinical Haematology, 2011, 24, 2, 165

    CrossRef

  35. 35
    Sergio Cortelazzo, Maurilio Ponzoni, Andrés J.M. Ferreri, Dieter Hoelzer, Lymphoblastic lymphoma, Critical Reviews in Oncology/Hematology, 2011, 79, 3, 330

    CrossRef

  36. 36
    Malou A Vermoolen, Marie José Kersten, Rob Fijnheer, Maarten S van Leeuwen, Thomas C Kwee, Rutger AJ Nievelstein, Magnetic resonance imaging of malignant lymphoma, Expert Review of Hematology, 2011, 4, 2, 161

    CrossRef

  37. 37
    Pier Luigi Zinzani, PET in T-Cell Lymphoma, Current Hematologic Malignancy Reports, 2011, 6, 4, 241

    CrossRef

  38. 38
    Shannon L MacDonald, Liam Mulroy, Derek R Wilke, Steven Burrell, PET/CT aids the staging of and radiotherapy planning for early-stage extranodal natural killer/T-cell lymphoma, nasal type: A case series, Radiation Oncology, 2011, 6, 1, 182

    CrossRef

  39. You have full text access to this Open Access content39
    Ukihide Tateishi, Mitsuaki Tatsumi, Takashi Terauchi, Kenichi Ishizawa, Michinori Ogura, Kensei Tobinai, Relevance of monitoring metabolic reduction in patients with relapsed or refractory follicular and mantle cell lymphoma receiving bendamustine: a multicenter study, Cancer Science, 2011, 102, 2
  40. 40
    Kheng-Wei Yeoh, N. George Mikhaeel, Role of Radiotherapy in Modern Treatment of Hodgkin's Lymphoma, Advances in Hematology, 2011, 2011, 1

    CrossRef

  41. 41
    X. Setoain, A. López-Guillermo, S. Rodríguez, I. Navales, TEP/TDM dans le diagnostic et la stadification des lymphomes, Médecine Nucléaire, 2011, 35, 1, 4

    CrossRef

  42. 42
    Hideaki Fujiwara, Yoshinobu Maeda, Yuichiro Nawa, Masayuki Yamakura, Daisuke Ennishi, Yukihiro Miyazaki, Katsuji Shinagawa, Masamichi Hara, Kosei Matsue, Mitsune Tanimoto, The utility of positron emission tomography/computed tomography in the staging of extranodal natural killer/T-cell lymphoma, European Journal of Haematology, 2011, 87, 2
  43. 43
    Masaharu Hata, Motoko Omura, Izumi Koike, Naoto Tomita, Yasuhito Iijima, Yoshibumi Tayama, Kazumasa Odagiri, Yumiko Minagawa, Ichiro Ogino, Tomio Inoue, Treatment Effects and Sequelae of Radiation Therapy for Orbital Mucosa-Associated Lymphoid Tissue Lymphoma, International Journal of Radiation Oncology*Biology*Physics, 2011, 81, 5, 1387

    CrossRef

  44. 44
    Yu-Yi Huang, Dong-Ling You, Mei-Ching Liu, Tran-Der Tan, Pei-Ing Lee, Ming-Yuan Lee, Underperformance of Gallium-67 Scan is Greater in Relapse Than in Initial Staging, Compared With FDG PET, Clinical Nuclear Medicine, 2011, 36, 10, 867

    CrossRef

  45. 45
    Peter J. Hosein, Vitor H. Pastorini, Fabio M. Paes, Daryl Eber, Jennifer R. Chapman, Aldo N. Serafini, Ash A. Alizadeh, Izidore S. Lossos, Utility of positron emission tomography scans in mantle cell lymphoma, American Journal of Hematology, 2011, 86, 10
  46. 46
    Ryogo Minamimoto, Miyako Morooka, Kazuo Kubota, Kimiteru Ito, Yoko Masuda-Miyata, Takuya Mitsumoto, Risen Hirai, Osamu Okazaki, Michiaki Hiroe, Value of FDG-PET/CT using unfractionated heparin for managing primary cardiac lymphoma and several key findings, Journal of Nuclear Cardiology, 2011, 18, 3, 516

    CrossRef

  47. 47
    Masahiro Okada, Norihide Sato, Kazunari Ishii, Kaname Matsumura, Makoto Hosono, Takamichi Murakami, FDG PET/CT versus CT, MR Imaging, and67Ga Scintigraphy in the Posttherapy Evaluation of Malignant Lymphoma1, RadioGraphics, 2010, 30, 4, 939

    CrossRef

  48. 48
    Shuji Yamamoto, Hiroshi Nakase, Kouhei Yamashita, Minoru Matsuura, Mariko Takada, Chiharu Kawanami, Tsutomu Chiba, Gastrointestinal follicular lymphoma: review of the literature, Journal of Gastroenterology, 2010, 45, 4, 370

    CrossRef

  49. 49
    Winnie K. S. Chan, Wing-Yan Au, Ching-Yee O. Wong, Raymond Liang, Anskar Y. H. Leung, Yok-Lam Kwong, Pek-Lan Khong, Metabolic Activity Measured by F-18 FDG PET in Natural Killer-Cell Lymphoma Compared to Aggressive B- and T-Cell Lymphomas, Clinical Nuclear Medicine, 2010, 35, 8, 571

    CrossRef

  50. 50
    Dominique Delbeke, Angelika Delaloye, Image-Guided Radiation Therapy in Lymphoma Management, 2010,

    CrossRef

  51. 51
    Ruth Pettengell, Advanced-Stage Follicular Lymphoma in the Rituximab Era, Drugs, 2009, 69, 13, 1727

    CrossRef

  52. 52
    Yiyan Liu, Clinical significance of diffusely increased splenic uptake on FDG-PET, Nuclear Medicine Communications, 2009, 30, 10, 763

    CrossRef

  53. 53
    Hye Kyung Shim, Won Woo Lee, So Yeon Park, Haeryoung Kim, Young So, Sang Eun Kim, Expressions of glucose transporter Types 1 and 3 and hexokinase-II in diffuse large B-cell lymphoma and other B-cell non-Hodgkin's lymphomas, Nuclear Medicine and Biology, 2009, 36, 2, 191

    CrossRef

  54. 54
    M. Ghielmini, E. Zucca, How I treat mantle cell lymphoma, Blood, 2009, 114, 8, 1469

    CrossRef

  55. 55
    Andrew M. Scott, Dishan H. Gunawardana, Joseph Wong, Ian Kirkwood, Rodney J. Hicks, Ivan Ho Shon, Jayne E. Ramshaw, Peter Robins, Positron emission tomography changes management, improves prognostic stratification and is superior to gallium scintigraphy in patients with low-grade lymphoma: results of a multicentre prospective study, European Journal of Nuclear Medicine and Molecular Imaging, 2009, 36, 3, 347

    CrossRef

  56. 56
    Thomas C. Kwee, Henriette M. E. Quarles van Ufford, Frederik J. Beek, Taro Takahara, Cuno S. Uiterwaal, Marc B. Bierings, Inge Ludwig, Rob Fijnheer, Rutger A. J. Nievelstein, Whole-Body MRI, Including Diffusion-Weighted Imaging, for the Initial Staging of Malignant Lymphoma, Investigative Radiology, 2009, 44, 10, 683

    CrossRef

  57. 57
    Saar Gill, Max Wolf, H. Miles Prince, Henry Januszewicz, David Ritchie, Rodney J. Hicks, John F. Seymour, [18F]Fluorodeoxyglucose Positron Emission Tomography Scanning for Staging, Response Assessment, and Disease Surveillance in Patients with Mantle Cell Lymphoma, Clinical Lymphoma and Myeloma, 2008, 8, 3, 159

    CrossRef

  58. 58
    Current Awareness in Hematological Oncology, Hematological Oncology, 2008, 26, 2
  59. 59
    Veli Berk, Ramazan Yildiz, Umit Ozgur Akdemir, Nalan Akyurek, Nese Ilgin Karabacak, Ugur Coskun, Mustafa Benekli, Disseminated Extranodal NK/T-Cell Lymphoma, Nasal Type, With Multiple Subcutaneous Nodules, Clinical Nuclear Medicine, 2008, 33, 5, 365

    CrossRef

  60. 60
    Sarah C. Rutherford, Biree Andemariam, Shibu M. Philips, Rebecca L. Elstrom, Amy Chadburn, Richard R. Furman, Ruben Niesvizky, Peter Martin, Thomas J. Fahey, Morton Coleman, Stanley J. Goldsmith, John P. Leonard, FDG-PET in prediction of splenectomy findings in patients with known or suspected lymphoma, Leukemia & Lymphoma, 2008, 49, 4, 719

    CrossRef

  61. 61
    Rebecca L. Elstrom, John P. Leonard, FDG-PET scans in patients with lymphoma, Current Hematologic Malignancy Reports, 2008, 3, 4, 197

    CrossRef

  62. 62
    T. C. Kwee, R. M. Kwee, R. A. J. Nievelstein, Imaging in staging of malignant lymphoma: a systematic review, Blood, 2008, 111, 2, 504

    CrossRef

  63. 63
    Lieselot Brepoels, Sigrid Stroobants, Walter De Wever, Daan Dierickx, Peter Vandenberghe, Jose Thomas, Luc Mortelmans, Gregor Verhoef, Christiane De Wolf-Peeters, Positron emission tomography in mantle cell lymphoma, Leukemia & Lymphoma, 2008, 49, 9, 1693

    CrossRef

  64. 64
    Ananth Shankar, Frank Fiumara, Ross Pinkerton, Role of FDG PET in the management of childhood lymphomas – case proven or is the jury still out?, European Journal of Cancer, 2008, 44, 5, 663

    CrossRef

  65. 65
    Martin Allen-Auerbach, Sven de Vos, Johannes Czernin, The Impact of Fluorodeoxyglucose–Positron Emission Tomography in Primary Staging and Patient Management in Lymphoma Patients, Radiologic Clinics of North America, 2008, 46, 2, 199

    CrossRef

  66. 66
    Andrea Janikova, Karol Bolcak, Tomas Pavlik, Jiri Mayer, Zdenek Kral, Value of [18F]Fluorodeoxyglucose Positron Emission Tomography in the Management of Follicular Lymphoma: The End of a Dilemma?, Clinical Lymphoma and Myeloma, 2008, 8, 5, 287

    CrossRef

  67. 67
    G. A. Salles, Clinical Features, Prognosis and Treatment of Follicular Lymphoma, Hematology, 2007, 2007, 1, 216

    CrossRef